© 2020 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Innovation Value Initiative
Latest from Innovation Value Initiative
Why Accounting for Our Differences Matter in Assessing Drug Value
June 01, 2020
Article
The authors discuss how more efforts need to ensure the methods used to measure the “value” of new therapies include factors that reflect patient heterogeneity.
Putting Patients First: IVI Launches Patient Advisory Council
May 08, 2020
Article
The Innovation and Value Initiative (IVI), a research-based non-profit improving the science and practice of value assessment, announced the appointment of seven members to its Patient Advisory Council, and advisory body designed to ensure the patient always remains at the forefront of value assessment.
PRESS RELEASE: Dr. Patricia Deverka Appointed as IVI's First Chief Science Officer
February 05, 2020
Article
The Innovation and Value Initiative (IVI) appoints Patricia Deverka, MD, as its first Chief Science Officer.
IVI Research Brief Uses Insurance Value to Determine Long-Term Value of Therapies
July 29, 2019
Article
A research brief from the Innovation and Value Initiative (IVI) looked at how the concept of insurance value can help stakeholders understand the value of therapies to the broader population.
IVI Research Brief Uses Patient Insights as Foundation for Value
May 28, 2019
Article
A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer patients’ perspectives and experiences shape cancer-related treatment decisions.
IVI Research Brief Explores Implications of "Value of Hope"
May 28, 2019
Article
A research brief from the Innovation and Value Initiative (IVI) took a look at how accounting for patients’ attitudes towards risks in treatment outcomes affects value.